Prevail Therapeutics Inc.
SEC CIK 1714798 · PRVL · last insider filing 2021-01-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Orbimed Advisors LLC | Director | filed 2019 - 2021 |
| Gordon Carl L | Director | filed 2019 - 2021 |
| Adams Timothy M | Director | filed 2019 - 2021 |
| Thompson Peter A. | Director | filed 2019 - 2021 |
| Nader Francois | Director | filed 2019 - 2021 |
| Nussbaum Ran | Director | filed 2019 - 2021 |
| Orbimed Capital GP VI LLC | Director | filed 2019 - 2021 |
| Abeliovich Asa | Director · President & CEO | filed 2019 - 2021 |
| Sheng Morgan | Director | filed 2019 - 2021 |
| Carson William H. | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hefti Franz | Chief Development Officer | filed 2019 - 2021 |
| Sevigny Jeffrey | Chief Medical Officer | filed 2019 - 2021 |
| Dai Yong | Chief Technology Officer | filed 2019 - 2021 |
| Minkow Emily | Chief Business Officer | filed 2019 - 2021 |
| Kaplan Brett | Chief Financial Officer | filed 2019 - 2021 |
| Schwartz Kira M. | General Counsel | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.